Nigeria Confirms First Ebola Case in a Decade

Nigeria has confirmed an Ebola case in Abuja, the country's first in more than a decade. The patient, a woman who travelled from Uganda, developed symptoms on 7 October and sought care at a private health facility in the capital four days later, according to the World Health Organization. Laboratory testing confirmed the diagnosis on 20 October. She remains in isolation and is receiving medical care while health authorities trace her contacts.

How the infection was spotted

The woman was admitted to the private hospital in Abuja after developing malaria-like symptoms. Doctors initially treated her for malaria, and Ebola was only suspected after her recent travel to Uganda came to light, according to Nigerian health officials. She was tested on 19 October, and the positive result was confirmed the following day.

Her condition has since worsened. Speaking at an emergency meeting in Abuja on Wednesday, Olajumoke Babatunde of the Nigeria Centre for Disease Control and Prevention said the patient has developed multi-organ failure. Babatunde said repeated molecular testing confirmed the Bundibugyo strain, a finding the WHO has independently verified. There is no approved vaccine or specific treatment for Bundibugyo Ebola, according to health officials.

The NCDC has identified 44 close contacts, including health workers at the private facility, other patients, caregivers, and people who travelled with the woman. All are being followed up closely. The agency has activated its incident management system to coordinate the response and is ramping up infection prevention and control measures at the facility where she sought care. Health authorities say the measures are aimed at preventing any further spread of the disease. The WHO is working closely with Nigerian authorities on the investigation and is helping provide essential supplies, including personal protective equipment for health workers, UN News reports.

An outbreak crossing the continent

Nigeria is the fifth country to detect Bundibugyo virus disease since the outbreak was declared in the Democratic Republic of the Congo in mid-May, according to the WHO. It is the deadliest outbreak in the DRC's history, with more than 9,500 infections and more than 4,200 deaths recorded by 18 October, according to Congolese health authorities. Uganda's outbreak was declared over in late August, while Kenya has reported nine infections and the Netherlands one, all linked to the DRC.

The Africa Centres for Disease Control and Prevention has responded by calling an Ebola crisis summit. Its director general, Jean Kaseya, posted that the disease is now affecting three regions of Africa and that the situation "demands urgent action and political leadership at the highest level." Health officials describe the DRC outbreak as the fastest-spreading Ebola outbreak on record, the Associated Press reports.

Nigerian physician Ayoade Alakija, who co-chairs a G7 committee on global health investment, told Reuters the jump from East Africa to West Africa turns this into "a pan-African event" rather than a problem confined to a few at-risk countries. The Bundibugyo species kills roughly half of those it infects, and no approved vaccine or treatment exists, according to the WHO.

What comes next

The WHO says containing the spread comes down to rapid identification of infections, timely follow-up of contacts, and strong infection prevention and control. The agency has advised all countries in the region to sustain a high level of readiness as the DRC outbreak continues to evolve, while stressing that governments should keep disease surveillance strong and laboratories able to test suspected cases safely. It has not recommended any restrictions on travel or trade with affected countries.

Nigeria has contained Ebola before. The country was declared Ebola-free in October 2014 after an outbreak that reached Lagos, an effort the WHO at the time called a remarkable success story, with every known contact in the city reached and monitored. This time the starting point is a single imported infection, and keeping it that way depends on the contact follow-up underway in Abuja and the regional surveillance the WHO says must stay at full alert.

More from the health desk: the first functional cure for hepatitis B wins FDA approval, peer-led HIV prevention beats clinics for young people, and psilocybin cooled inflammation in Parkinson's patients.